Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 3 of the 11 sources its claims cite were checked for support.
Abstract
The quantitative contributions of pancreatic responsiveness and insulin sensitivity to glucose tolerance were measured using the "minimal modeling technique" in 18 lean and obese subjects (88-206% ideal body wt). The individual contributions of insulin secretion and action were measured by interpreting the dynamics of plasma glucose and insulin during the intravenous glucose tolerance test in terms of two mathematical models. One, the insulin kinetics model, yields parameters of first-phase (phi 1) and second-phase (phi 2) responsivity of the beta-cells to glucose. The other glucose kinetics model yields the insulin sensitivity parameters, SI. Lean and obese subjects were subdivided into good (KG greater than 1.5) and lower (KG less than 1.5) glucose tolerance groups. The etiology of lower glucose tolerance was entirely different in lean and obese subjects. Lean, lower tolerance was related to pancreatic insufficiency (phi 2 77% lower than in good tolerance controls [P less than 0.03]), but insulin sensitivity was normal (P greater than 0.5). In contrast, obese lower tolerance was entirely due to insulin resistance (SI diminished 60% [P less than 0.01]); pancreatic responsiveness was not different from lean, good tolerance controls (phi 1: P greater than 0.06; phi 2: P greater than 0.40). Subjects (regardless of weight) could be segregated into good and lower tolerance by the product of second-phase beta-cell responsivity and insulin sensitivity (phi 2 . SI). Thus, these two factors were primarily responsible for overall determination of glucose tolerance. The effect of phi 1 was to modulate the KG value within those groups whose overall tolerance was determined by phi 2 . SI. This phi 1 modulating influence was more pronounced among insulin sensitive (phi 1 vs. KG, r = 0.79) than insulin resistant (obese, low tolerance; phi 1 vs. KG, r = 0.91) subjects. This study demonstrates the feasibility of the minimal model technique to determine the etiology of impaired glucose tolerance.
Overview
CoChat Summary
TL;DR
The paper applies the “minimal modeling” technique to intravenous glucose tolerance tests in 18 lean and obese subjects to quantify insulin sensitivity and β-cell glucose responsiveness. It finds that low glucose tolerance in lean subjects is due mainly to pancreatic insufficiency, whereas in obese subjects it is due mainly to insulin resistance.
Key findings
- Lean subjects with lower glucose tolerance had a 77% lower second-phase β-cell responsivity (φ2) than lean good-tolerance controls (P < 0.03), while insulin sensitivity was normal (P > 0.5).
- Obese subjects with lower glucose tolerance had insulin sensitivity diminished by 60% versus lean good-tolerance controls (P < 0.01), with pancreatic responsiveness not significantly different (φ1: P > 0.06; φ2: P > 0.40).
- The product φ2·S segregated tolerance: good-tolerance subjects averaged 160 ± 26 versus 40 ± 7 for low-tolerance subjects (P < 0.001); a φ2·S threshold of 75 separated 9 of 10 low-tolerance and 7 of 8 good-tolerance subjects.
- First-phase responsivity (φ1) modulated KG within groups: φ1 vs KG correlated r = 0.79 in insulin-sensitive subjects and r = 0.91 in insulin-resistant obese low-tolerance subjects; glucose effectiveness (P1) was lower in low-tolerance subjects (1.4 ± 0.2 vs. 3.6 ± 0.3 %/min, P < 0.01).
Methods
- IVGTT was performed in 18 subjects (8 male, 10 female; 88–206% ideal body weight) after an overnight fast, with 300 mg/kg glucose injected over 60 s and frequent plasma glucose and insulin sampling.
- Two minimal mathematical models were used: a glucose kinetics model to estimate insulin sensitivity (S) and an insulin kinetics model to estimate first-phase (φ1) and second-phase (φ2) β-cell responsivity to glucose.
- Parameters were estimated by nonlinear least squares with covariance-matrix accuracy assessment; subjects were divided into good tolerance (KG > 1.5) and lower tolerance (KG < 1.5), and comparisons used Student’s t test and regression.
Limitations
- The paper states that complete validation of the model and optimal input patterns is required before the approach can be proposed as a clinical tool, and that more study of the range of glucose doses over which the model applies would be worthwhile.
- The authors note that the present studies were limited to testing whether the model and its parameters apply and can be obtained from other doses and stimulus patterns.
- Evident from the text: the sample is small (n = 18), the tolerance cutoff at KG = 1.5 was arbitrary because no KG values fell between 1.4 and 1.8, and φ1 varied widely within groups, limiting clear segregation by φ1·S.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




![FiGURE 4 Ability of the minimal models to describe glucose and insulin kinetics during the IVGTT (examples). Insulin and glucose data are represented by open (O) and filled () circles. Prediction of the insulin kinetics model are the solid curves; upper panels. Glucose kinetics model predicts the time-course of plasma glucose (solid curves, lower panels) as well as the timecourse of "insulin action" (dashed line upper panels; remote insulin [X] in the model of Fig. la).](https://figures.cochat.ai/paper-figures/f6e06f75ebdc4bef964605372991c28c/physiologic-evaluation-of-factors-controlling-glucose-tolerance-in-man-figure-4.png)



Verification
Claims the paper makes
2 Valid · 0 Not valid · 4 Not checked · 44 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“During the past decade, several laboratories have approached this problem by breaking the feedback relationship, either by pharmacological suppression of pancreatic insulin secretion (10) or by external feedback control (glucose clamp) to circumvent the effect of plasma insulin to change plasma glucose (11).”
What the sources say
- Supportedcites [10] 10. Shen, S-W., G. M. Reaven, and J. W. Farquhar. 1970. Comparison of impedance to insulin-mediated glucose uptake in normal and diabetic subjects.J. Clin. Invest. 49: 2151-2160. source
The Introduction (p. 1, 'Dr. Shen is a Postdoctoral Research Fellow' section) states the approach the citing sentence attributes to this reference: subjects received a constant intravenous infusion of exogenous crystalline insulin while 'endogenous insulin secretion was inhibited by the simultaneous administration of low doses of epinephrine and propranolol,' so that the steady-state plasma glucose during a constant glucose infusion measures impedance to insulin-mediated glucose uptake, and such measurements 'should eliminate some of the variables of an intact feedback loop.' The Discussion ('§ Values obtained from') confirms the pharmacological blockade worked (immunoreactive insulin fell to <50% of fasting and remained low despite plasma glucose of 316 and 398 mg/100 ml), and that its primary goal was to consider only a constant level of exogenous insulin. Our copy does not describe external feedback control (glucose clamp), but that half of the sentence is carried by the separate citation (11), not by this source; likewise 'during the past decade, several laboratories' is the citing authors' framing. Note the propranolol-epinephrine inhibition method is credited to Porte (ref 36), but Shen et al. report and rely on it as their own experimental approach, so the identification citation stands. (LLM, conf=0.88)
- Supportedcites [11] 11. Insel, P. A., J. E. Liljenquist, J. D. Tobin, R. S. Sherwin, P. Watkins, R. Andres, and M. Berman. 1975. Insulin control of glucose metabolism in man. J. Clin. Invest. 55: 1057-1066. source
The citation is attached to the glucose-clamp branch of the sentence (the pharmacological-suppression branch carries a different reference), and our copy is exactly that kind of work: the Introduction (p. 1057) states that 'the maintenance of blood sugar in man is a complex process involving feedback control of insulin on glucose and of glucose on insulin' and that 'by use of the glucose clamp technique (1, 2), the blood glucose concentration is maintained by a feedback-controlled glucose infusion.' The Abstract (p. 1057) confirms the purpose — insulin-induced changes in blood glucose activate counterregulatory mechanisms, 'to eliminate such mechanisms, we have employed the glucose clamp technique which allows maintenance of fasting blood glucose concentration,' and the Discussion (p. 1063) presents the clamp (with kinetic modeling) as an approach to estimating tissue sensitivity to insulin, contrasting it with the insulin tolerance test and 'glucose impedance.' The 'several laboratories' framing is the citing authors' own summary, not a point attributed to this source. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Thus, our results are consistent with the diminished S of obese subjects elucidated by both qualitative (26) and quantitative techniques (25).”
What the sources say
- Not checked — no full text of the sourcecites [26] 26. Kolterman, O., G. M. Reaven, and J. M. Olefsky. 1979. Relationship between in vivo insulin resistance and decreased insulin receptors in obese men. J. Clin. Endocrinol. Metab. 48: 487-494. source
- Supportedcites [25] 25. DeFronzo, R., V. Soman, R. Sherwin, R. Hendler, and P. Felig. 1979. Insulin binding to monocytes and insulin action in human obesity, starvation and refeeding. J. Clin. Invest. 63: 204–213. source
The citation is attached to “quantitative techniques.” The Discussion reports that insulin sensitivity was quantified with the euglycemic insulin clamp and was 52% lower in postabsorptive obese subjects. This supports the attributed finding of diminished insulin sensitivity (S); the qualitative-techniques citation is separate. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the obese glucose space exceeded the space of lean individuals by only 16% (Table II).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“an increase of φ1 from 1 to 10 was associated with an increase in KG of only 0.3 min−¹.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because the diminished glucose effectiveness of obese subjects is independent of acute changes in insulin”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
27 more claims
Create a free account to see all 50 claims and every source verdict.
- Probably not a substantial claim. 8
- It may state two separate claims as one. 14
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As postulated previously [93], we found that the relationship between insulin sensitivity and insulin secretion is non-linear and best described by a hyperbolic function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [93]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These studies have demonstrated that to maintain glucose homeostasis, a feedback loop exists in which decreased insulin sensitivity is tightly associated with increased insulin secretion from the beta cell, with this hyperbolic relationship between beta cell responsivity and insulin sensitivity termed the disposition index67,68.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [68]
Experimental — accuracy not yet measuredIn the citing paper
“the product of insulin sensitivity and the acute insulin response to intravenous glucose, called the disposition index [93], declined in the group as a whole and was associated with a mild deterioration of intravenous glucose tolerance.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 6 | 1.06 | 8.9 | 5.1 | 1.4 | 4.5 |”
Reported 4.5 · recomputed 45.39
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ RESULTS · p. 7
“In the glucose kinetics model (Fig. 1b) the coefficient P1 is the insulin-independent fractional turnover constant for glucose disposition”
§ B MINIMAL MODEL OF INSULIN KINETICS · p. 3
“(B) Model of insulin kinetics used to calculate pancreatic responsivity parameters φ1 and φ2 (12).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ METHODS · p. 2
“glucose (300 mg/kg) was injected smoothly over 60 s, starting at time (t) = 0.”
§ RESULTS · p. 6
“Glucose (330 mg/kg) was injected over 1 min starting at t = 0.”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1172/jci109108 · retraction date not known · this paper published 1981-12-01
Citations
Cites
1 retracted
Insulin Binding to Monocytes and Insulin Action in Human Obesity, Starvation, and Refeeding
Defronzo, R. A., Soman, V., Sherwin, R. S., Hendler, R., & Felig, P. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109108 · Cited by 252
RetractedQuantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 4×
“We have referred to the sum of these factors as "glucose effectiveness" (13).”
InfluentialSelf-citationExcessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay
Karam, J. H., Grodsky, G. M., Forsham, P. H., & McWilliams, N. B. (1963) · Diabetes · doi:10.2337/diab.12.3.197 · Cited by 591
Rabinowitz, D., & Zierler, K. L. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104676 · Cited by 521
Shen, S.-W., Reaven, G. M., & Farquhar, J. W. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106433 · Cited by 494
A model of the kinetics of insulin in man
Sherwin, R. S., Kramer, K. J., Tobin, J. D., Insel, P. A., Liljenquist, J. E., Berman, M., & Andres, R. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107697 · Cited by 460
A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling
Grodsky, G. M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107011 · Cited by 395
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Statistical Analysis: A Computer Oriented Approach.
Pektau, A. J., Afifi, A. A., & Azen, S. P. (1980) · Journal of the American Statistical Association · doi:10.2307/2287217 · Cited by 324
Toffolo, G., Bergman, R. N., Finegood, D. T., Bowden, C. R., & Cobelli, C. (1980) · Diabetes · doi:10.2337/diab.29.12.979 · Cited by 292
Self-citation
Research works printed but not linked: 2
- [18]18. Goodwin, C., and R. L. Payne. 1977. Dynamic System Identification. Academic Press, Inc., New York.
- [14]14. Bergman, R. N., C. R. Bowden, and C. Cobelli. 1981. The minimal model approach to quantification of factors controlling glucose disposal in man. In Carbohydrate Metabolism: Quantitative Physiology and Mathematical Modeling. C. Cobelli, and R. Bergman, editors. John Wiley & Sons, Inc., London. 269–296.
Cited by
Items 701–800 of 1,647
Farman, M. T., Hasan, A., Xu, C., Nisar, K. S., & Hınçal, E. (2024) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2024.108420 · Cited by 23
Tang, C., Yeung, L. S. N., Koulajian, K., Zhang, L., Tai, K., Volchuk, A., & Giacca, A. (2018) · Endocrinology · doi:10.1210/en.2018-00566 · Cited by 26
Linear Model Identification for Personalized Prediction and Control in Diabetes
Faccioli, S., Facchinetti, A., Sparacino, G., Pillonetto, G., & Favero, S. D. (2021) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2021.3101589 · Cited by 34
The Classification of Diabetes Mellitus: A Conceptual Framework
Ize-Ludlow, D., & Sperling, M. A. (2005) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2005.07.001 · Cited by 27
On-line policy learning and adaptation for real-time personalization of an artificial pancreas
Paula, M. D., Acosta, G. G., & Martínez, E. (2014) · Expert Systems with Applications · doi:10.1016/j.eswa.2014.10.038 · Cited by 30
Yasini, S., Karimpour, A., & Sistani, M. B. N. (2012) · IETE Journal of Research · doi:10.4103/0377-2063.102314 · Cited by 22
Olveira, G., Tapia, M. J., Ocón, J., Cabrejas-Gómez, C., Ballesteros-Pomar, M. D., Vidal‐Casariego, A., Irigoyen, C. A., Olivares, J., Conde-García, M. C., García‐Manzanares, Á., et al. (2014) · Endocrine Practice · doi:10.4158/ep13441.or · Cited by 29
Agent-Based Simulation For Blood Glucose Control In Diabetic Patients
Yasini, S., Sistani, M. B. N., & Karimpour, A. (2009) · doi:10.5281/zenodo.1060214 · Cited by 22
Nath, A., Dey, R., & Bălaş, V. E. (2017) · Advances in intelligent systems and computing · doi:10.1007/978-3-319-62524-9_23 · Cited by 28
Optimal regulation of blood glucose level in Type I diabetes using insulin and glucagon
Shirin, A., Rossa, F. D., Klickstein, I. S., Russell, J. J., & Sorrentino, F. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213665 · Cited by 27
Grancini, V., Trombetta, M., Lunati, M. E., Boselli, M. L., Gatti, S., Donato, M. F., Palmieri, E., Resi, V., Pugliese, G., Bonadonna, R. C., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.015 · Cited by 23
Insulin Secretion and Insulin Sensitivity in Relation to Fasting Glucose in Healthy Subjects
Åhrén, B. (2007) · Diabetes Care · doi:10.2337/dc06-1759 · Cited by 22
Effects of Ω-3 (n-3) Fatty Acid Supplementation on Insulin Sensitivity in Horses
Hess, T. M., Rexford, J., Hansen, D. K., Ahrens, N. S., Harris, M., Engle, T. E., Ross-Jones, T., & Allen, K. G. D. (2012) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2012.07.007 · Cited by 26
Expression of FOXC2 in adipose and muscle and its association with whole body insulin sensitivity
Di Gregorio, G. B., Westergren, R., Enerback, S., Lu, T., & Kern, P. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00155.2004 · Cited by 22
Model-based nonlinear optimal blood glucose control of Type I diabetes patients
Kovács, L., Kulcsár, B., Bokor, J., & Benyó, Z. (2008) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2008.4649480 · Cited by 24
INS VNTR is a QTL for the insulin response to oral glucose in obese children
Santos, C. D., Fallin, M. D., Stunff, C. L., Fur, S. L., & Bougneres, P. F. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00024.2003 · Cited by 24
On Insulin Action in Vivo: The Single Gateway Hypothesis
Bergman, R. N., Bradley, D. C., & Ader, M. (1993) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2910-1_13 · Cited by 22
Self-citationDelineating the relationship between stress, depressive symptoms, and glucose intolerance.
Grandinetti, A., Kaholokula, J. K., & Chang, H. K. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1443 · Cited by 25
Klonoff, D. C., Bergenstal, R. M., Cengiz, E., Clements, M. A., Espes, D., Espinoza, J., Kerr, D. E., Kovatchev, B. P., Maahs, D. M., Mader, J. K., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251353228 · Cited by 37
Insulin sensitivity and brain reward activation in overweight H ispanic girls: a pilot study
Adam, T. C., Tsao, S., Page, K. A., Hu, H., Hasson, R. E., & Goran, M. I. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2013.00210.x · Cited by 23
Insulin signaling in the whole spectrum of GH deficiency
Garmes, H. M., & Castillo, A. R. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000188 · Cited by 25
de Hoogh, I. M., Oosterman, J. E., Otten, W., Krijger, A.-M., Berbée, S., Pasman, W. J., van Ommen, B., Pijl, H., & Wopereis, S. (2021) · Nutrients · doi:10.3390/nu13072193 · Cited by 27
Examining Type 1 Diabetes Mathematical Models Using Experimental Data
Ali, H. A., Daneshkhah, A., Boutayeb, A., & Mukandavire, Z. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19020737 · Cited by 25
Insulin Resistance in the Polycystic Ovary Syndrome
Book, C.-B. S., & Dunaif, A. E. (1996) · Springer eBooks · doi:10.1007/978-1-4613-8483-0_8 · Cited by 21
Systems analysis and the prediction and prevention of Type 2 diabetes mellitus
Bergman, R. N., Stefanovski, D., & Kim, S. P. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.05.007 · Cited by 24
Self-citationIVGTT glucose minimal model covariate selection by nonlinear mixed-effects approach
Denti, P., Bertoldo, A., Vicini, P., & Cobelli, C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00656.2009 · Cited by 21
Self-citationIdentification and low-complexity regime-switching insulin control of type I diabetic patients
حریری, ع. م., & Wang, L. Y. (2011) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2011.44040 · Cited by 21
Computational study of an augmented minimal model for glycaemia control
Markakis, M. G., Mitsis, G. D., & Marmarelis, V. Z. (2008) · 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society · doi:10.1109/iembs.2008.4650446 · Cited by 21
“On the other hand, most of the minimal models proposed to date like [4]-[6] try to represent only a part of the actual dynamics, by completely disregarding the effects of glucagon and neglecting the procedure of endogenous insulin production.”
BackgroundJaradat, M. A., Sawaqed, L., & Alzgool, M. (2020) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2020.101922 · Cited by 21
Kriventsov, S., Lindsey, A., & Hayeri, A. (2020) · JMIR Diabetes · doi:10.2196/18660 · Cited by 23
Amoah, A. G. B., Schuster, D. P., Gaillard, T. R., & Osei, K. (2002) · PubMed · Cited by 21
Lehtovirta, M., Kaprio, J. A., Groop, L., Trombetta, M., & Bonadonna, R. C. (2005) · Diabetologia · doi:10.1007/s00125-005-1815-2 · Cited by 22
Islet Phospholipase A2 Activation Is Potentiated in Insulin Resistant Mice
Simonsson, E., Karlsson, S., & Åhrén, B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2820 · Cited by 21
Automated Insulin Infusion Trials in the Intensive Care Unit
Doran, C. V., Chase, J. G., Shaw, G. M., Moorhead, K. T., & Hudson, N. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504773731348 · Cited by 22
Lekakis, J. P., Anastasiou, E., Papamichael, C. M., Stamatelopoulos, K. S., Dagre, A. G., Alevizaki, M., & Stamatelopoulos, S. F. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1432a · Cited by 24
Sugden, M. C., Greenwood, G. K., Smith, N. D., & Holness, M. J. (2002) · Endocrinology · doi:10.1210/en.2002-220811 · Cited by 24
Forst, T. M., Standl, E., Hohberg, C., Konrad, T., Schulze, J., Strotmann, H.-J., Lübben, G., Pähler, S., Bachinger, A., Langenfeld, M. R. W., et al. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01298.x · Cited by 22
Cobelli, C., & Ruggeri, A. (1991) · IEEE Transactions on Biomedical Engineering · doi:10.1109/10.88447 · Cited by 21
Self-citationLindåse, S. S., Nostell, K. E. A., Söder, J., & Bröjer, J. T. (2017) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14799 · Cited by 23
Herrgårdh, T., Li, H., Nyman, E., & Cedersund, G. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.619254 · Cited by 23
Yan, S., Ding, L., & Cai, Y. (2025) · Fuzzy Sets and Systems · doi:10.1016/j.fss.2025.109486 · Cited by 29
Roy, A. (2008) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 25
Measurement of insulin action: a tribute to Sir Harold Himsworth
Kim, S. H. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03409.x · Cited by 26
The Artificial Pancreas: Is it Important to Understand How the β Cell Controls Blood Glucose?
Steil, G. M., & Grodsky, G. M. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700528 · Cited by 23
Qvigstad, E., Voldner, N., Godang, K., Henriksen, T., & Bollerslev, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0416 · Cited by 20
Liang, P., Xi, L., Shi, J., Li, W., Zhao, S., Deng, Y., Wang, R., Sun, Y., Gu, B., Yuan, L., et al. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.12.029 · Cited by 23
Model for Simulating Fasting Glucose in Type 2 Diabetes and the Effect of Adherence to Treatment
Aradóttir, T. B., Boiroux, D., Bengtsson, H. L., Kildegaard, J., Orden, B. V., & Jørgensen, J. B. (2017) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2017.08.2527 · Cited by 21
Price, C. A., Craig, C. M., Spielman, D. M., Cushman, S. S., & McLaughlin, T. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0191-1 · Cited by 21
Control-Oriented Model With Intra-Patient Variations for an Artificial Pancreas
Moscoso-Vásquez, M., Colmegna, P. H., Rosales, N., Garelli, F., & Sánchez‐Peña, R. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.2969389 · Cited by 24
Jain, P., Joshi, A., & Mohanty, S. (2020) · World Forum on Internet of Things · doi:10.1109/wf-iot48130.2020.9221132 · Cited by 24
Golestani, F., & Tavazoei, M. S. (2021) · European Journal of Control · doi:10.1016/j.ejcon.2021.11.002 · Cited by 22
Pietrzak-Nowacka, M., Safranow, K., Byra, E., Nowosiad, M., Marchelek‐Myśliwiec, M., & Ciechanowski, K. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2010.527012 · Cited by 21
Circadian Rhythms, Metabolism, and Insulin Sensitivity: Transcriptional Networks in Animal Models
Kitazawa, M. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0354-8 · Cited by 20
Derivative weighted active insulin control algorithms and intensive care unit trials
Doran, C. V., Chase, J. G., Shaw, G. M., Moorhead, K. T., & Hudson, N. (2005) · Control Engineering Practice · doi:10.1016/j.conengprac.2004.10.009 · Cited by 20
Li, P., Yu, L., Fang, Q., & Lee, S.-Y. (2015) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-015-1436-y · Cited by 22
Prevention of type 2 diabetes mellitus in polycystic ovary syndrome: A review
Anwar, S., & Shikalgar, N. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.07.015 · Cited by 20
Maloff, B. L., & Boyd, B. (1986) · Diabetologia · doi:10.1007/bf00452066 · Cited by 19
Tripathy, D., Lindholm, E., Isomaa, B., Saloranta, C., Tuomi, T., & Groop, L. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00113.2003 · Cited by 20
Sleep Apnea and Metabolic Dysfunction
Punjabi, N. M., & Beamer, B. A. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50093-8 · Cited by 23
Cobelli, C., & Man, C. D. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211015268 · Cited by 24
Self-citationJagannathan, R., Snehalatha, C., Selvam, S., Nanditha, A., Shetty, A. S., Godsland, I. F., Johnston, D. G., & Ramachandran, A. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0718-z · Cited by 20
An adaptive back-stepping control for blood glucose regulation in type 1 diabetes
Sepasi, S., Kalat, A. A., & Seyedabadi, M. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.102498 · Cited by 19
Burden, H. J., Adams, S. E., Kulatea, B., Wright‐McNaughton, M., Sword, D., Ormsbee, J. J., Watene-O’Sullivan, C., Merriman, T. R., Knopp, J. L., Chase, J. G., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05552-x · Cited by 24
Tabassum, M. F., Farman, M. T., Naik, P. A., Ahmad, A., Ahmad, A. S., & Hassan, S. M. U. (2021) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-021-00316-4 · Cited by 18
Robust H∞ control of T–S fuzzy blood glucose regulation system via adaptive event-triggered scheme
Yan, S., Chu, L.-L., & Cai, Y. (2023) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2023.104643 · Cited by 21
Lytrivi, M., Cauduro, C. G. D. S., Kibanda, J., Kristanto, P., Paesmans, M., & Cnop, M. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.07.018 · Cited by 21
García-Jaramillo, M., Calm, R., Bondía, J., & Vehí, J. (2012) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2012.04.003 · Cited by 23
Gresl, T. A., Baum, S. T., & Kemnitz, J. W. (2000) · Zoo Biology · doi:10.1002/1098-2361(2000)19:3<193::aid-zoo3>3.0.co;2-m · Cited by 19
Sweatman, C. Z. W. H. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.110037 · Cited by 22
Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus
Guerrero‐Romero, F., & Rodríguez‐Morán, M. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01728.x · Cited by 19
The effect of Diamicron® on the secretion and action of insulin
Chiasson, J., Hamet, P., & Verdy, M. (1991) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(91)90007-z · Cited by 22
Tokuyama, Y., Sakurai, K., Yagui, K., Hashimoto, N., Saitō, Y., & Kanatsuka, A. (2001) · Metabolism · doi:10.1053/meta.2001.24217 · Cited by 19
Cabezas-Cerrato, J., Estévez, D. A. G., Araújo, D. R., & Iglesias, M. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90298-5 · Cited by 18
Modelling and control of hyperglycemia in critical care patients
Doran, C. V. (2004) · UC Research Repository (University of Canterbury) · doi:10.26021/2983 · Cited by 24
Lützhøft, D. O., Bækgård, C., Wimborne, E. A., Straarup, E. M., Pedersen, K., Swann, J. R., Pedersen, H. D., Kristensen, K., Morgills, L., Nielsen, D. S., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0298602 · Cited by 19
Fasting Indicators of Insulin Sensitivity: Effects of Ethnicity and Pubertal Status
Adam, T. C., Hasson, R. E., Lane, C. J., Davis, J. N., Weigensberg, M. J., Spruijt‐Metz, D., & Goran, M. I. (2011) · Diabetes Care · doi:10.2337/dc10-1593 · Cited by 18
Boiroux, D., Hagdrup, M., Mahmoudi, Z., Poulsen, N. K., Madsen, H., & Jørgensen, J. B. (2016) · European Control Conference (ECC) · doi:10.1109/ecc.2016.7810604 · Cited by 19
ALFORD, F. P., Henriksen, J. E., Rantzau, C., & Beck‐Nielsen, H. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2989 · Cited by 20
Yang, J. F., Gong, X., Bakh, N. A., Carr, K. M., Phillips, N. F. B., Ismail‐Beigi, F., Weiss, M. A., & Strano, M. S. (2020) · Diabetes · doi:10.2337/db19-0879 · Cited by 20
Quiroz, G., & Femat, R. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.11.015 · Cited by 21
Atypical antipsychotic drugs, diabetes and ethnicity
Ananth, J., Kolli, S., Gunatilake, S., & Brown, S. R. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.6.1111 · Cited by 20
Mathematical Modeling of the Blood Glucose Regulation System in Diabetes Mellitus Patients
Александрович, К. В., Philippov, Y. I., Tarasov, Y. V., Boyarsky, M. D., Mayorov, A. Y., Shestakova, M. V., & Dedov, I. I. (2015) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v70.i5.1441 · Cited by 27
Robustness properties of optimal insulin bolus administrations for Type 1 diabetes
Kirchsteiger, H., del Re, L., Renard, É., & Mayrhofer, M. (2009) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.1109/acc.2009.5160729 · Cited by 21
Effects of metformin in obese patients with impaired glucose tolerance
Scheen, A. J., Letiexhe, M. R., & Lefèbvre, P. J. (1995) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610110511 · Cited by 18
Banzi, W., Kambutse, I., Dusabejambo, V., Rutaganda, E., Minani, F., Niyobuhungiro, J., Mpinganzima, L., & Ntaganda, J. M. (2021) · International Journal of Mathematics and Mathematical Sciences · doi:10.1155/2021/6660177 · Cited by 25
A physical activity-intensity driven glycemic model for type 1 diabetes
Hobbs, N., Samadi, S., Rashid, M. M., Shahidehpour, A., Askari, M. R., Park, M., Quinn, L., & Çınar, A. (2022) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2022.107153 · Cited by 19
Hypoglycemic effects and mechanisms of electroacupuncture on insulin resistance
Yin, J., Kuang, J., Chandalia, M., Tuvdendorj, D., Tumurbaatar, B., Abate, N. I., & Chen, J. D. Z. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00465.2013 · Cited by 17
Gestational diabetes mellitus: definition, aetiological and clinical aspects
Baz, B., & Riveline, J. (2016) · Cited by 17
Heydarinejad, H., & Delavari, H. (2016) · Lecture notes in electrical engineering · doi:10.1007/978-3-319-45474-0_18 · Cited by 17
Blood glucose control using an ABC algorithm-based fuzzy-PID controller
Soylu, S., & Danışman, K. (2018) · TURKISH JOURNAL OF ELECTRICAL ENGINEERING & COMPUTER SCIENCES · doi:10.3906/elk-1704-203 · Cited by 17
Sensor-Augmented Pump-Based Customized Mathematical Model for Type 1 Diabetes
Grosman, B., Wu, D., Miller, D. M., LINTEREUR, L. J., Roy, A., Parikh, N., & KAUFMAN, F. R. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0333 · Cited by 18
Interpretation of Retrospective BG Measurements
Stewart, K. W., Pretty, C. G., Shaw, G. M., & Chase, J. G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818786518 · Cited by 18
A review on control-relevant glucose–insulin dynamics models and regulation strategies
Bhonsle, S., & Saxena, S. (2019) · Proceedings of the Institution of Mechanical Engineers Part I Journal of Systems and Control Engineering · doi:10.1177/0959651819870328 · Cited by 28
Identifiability of Control-Oriented Glucose-Insulin Linear Models: Review and Analysis
Hoyos, J. D., Villa-Tamayo, M. F., Builes-Montaño, C. E., Rincón, A. R., Godoy, J. L., Garcia‐Tirado, J., & Rivadeneira, P. S. (2021) · IEEE Access · doi:10.1109/access.2021.3076405 · Cited by 18
Diabetes Mellitus Complicating Pregnancy
Landon, M. B., Catalano, P. M., & Gabbe, S. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1935-2.00039-9 · Cited by 23
Dungan, K. M., Hart, P. A., Andersen, D. K., Basina, M., Chinchilli, V. M., Danielson, K. K., Evans‐Molina, C., Goodarzi, M. O., Greenbaum, C. J., Kalyani, R. R., et al. (2022) · Pancreas · doi:10.1097/mpa.0000000000002074 · Cited by 18
Watanabe, Y., Singamsetty, S., Zou, B., Guo, L., Stefanovski, D., Alonso, L. C., Garcı́a-Ocaña, A., O'Donnell, C. P., & McVerry, B. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067716 · Cited by 17
Predicting Glucose Effectiveness in Chinese Participants Using Routine Measurements
Chen, Y., Lee, S.-F., Pei, C., Pei, D., Lee, C., He, C., Liang, Y.-J., & Lin, J. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0136 · Cited by 17
Asadi, S., & Nekoukar, V. (2018) · Mathematical Biosciences · doi:10.1016/j.mbs.2018.09.006 · Cited by 17
Borgeraas, H., Hjelmesaeth, J. S., Birkeland, K. I., Fatima, F., Grimnes, J. O., Gulseth, H. L., Halvorsen, E., Hertel, J. K., Hillestad, T. O. W., Johnson, L. K., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024573 · Cited by 18
Metadata
- Authors
- Bergman, R. N., Phillips, L. S., & Cobelli, C.
- Affiliations
- Northwestern University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1981-12-01
- Volume
- 68
- Issue
- 6
- Pages
- 1456-1467
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC370948
- OpenAlex
- W2156353972
- Cited by
- 1,640
- References
- 30
- Citations by year
- 2026: 32 · 2025: 38 · 2024: 44 · 2023: 31 · 2022: 45 · 2021: 59 · 2020: 50 · 2019: 55 · 2018: 66 · 2017: 66 · 2016: 59 · 2015: 63 · 2014: 60 · 2013: 59 · 2012: 73
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Northwestern University
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK029867)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glucose tolerance, insulin sensitivity, beta-cell glucose sensitivity, insulin resistance, pancreatic insufficiency, intravenous glucose tolerance test, first-phase insulin response, second-phase insulin response, obesity, impaired glucose tolerance, insulin kinetics, glucose kinetics
- MeSH terms
- Body Weight, Female, Glucose, Glucose Tolerance Test, Humans, Infusions, Parenteral, Insulin, Kinetics, Male, Models, Biological, Obesity, Pancreas
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.